Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: A prospective, randomized, multicenter study

Diabetes Care

Volumn 31, Issue 1, 2008, Pages 15-19

  Tomai, Fabrizio ^a   Reimers, Bernhard ^b   De Luca, Leonardo ^a   Galassi, Alfredo R ^c   Gaspardone, Achille ^d   Ghini, Anna S ^a   Ferrero, Valeria ^e   Favero, Luca ^b   Gioffrè, Gaetano ^d   Prati, Francesco ^f   Tamburino, Corrado ^c   Ribichini, Flavio ^e  

^a EUROPEAN HOSPITAL   (Italy)

^b Mirano Hospital   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d S EUGENIO HOSPITAL   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; PACLITAXEL; RAPAMYCIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DIET THERAPY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG IMPLANTATION; FEMALE; FOLLOW UP; HEART VENTRICLE HYPERTROPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; DIABETIC ANGIOPATHY; MIDDLE AGED;

AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 38349002490     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1377     Document Type: Article

References (19)

1. Berry C, Tardif JC, Bourassa MG: Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization. J Am Coll Cardiol 49:643-656, 2007
2. Moses JW, Leon MB, Popma JJ, PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323, 2003
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, the TAXUS-IV Investigators: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231, 2004
4. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ: A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364:583-591, 2004
5. Finn AV, Palacios IF, Kastrati A, Gold HK: Drug-eluting stents for diabetes mellitus: a rush to judgment? J Am Coll Cardiol 45:479-483, 2005
6. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R, Goicolea J, Banuelos C, Escaned J, Moreno R, Fernandez C, Fernandez-Aviles F, Macaya C, the DIABETES Investigators: Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. Circulation 112:2175-2183, 2005
7. Daemen J, Garcia-Garcia HM, Kukreja N, Imani F, de Jaegere PP, Sianos G, van Domburg RT, Serruys PW: The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. Eur Heart J 28:26-32, 2007
8. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schomig A, the ISAR-DIABETES Study Investigators: Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353:663-670, 2005
9. Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P: Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart 92:650-657, 2006
10. Scheen AJ, Warzee F, Legrand VM: Drug-eluting stents: meta-analysis in diabetic patients. Eur Heart J 25:2167-2168, 2004
11. Ong AT, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M, Tsuchida K, Sonnenschein K, Regar E, van der Giessen WJ, de Jaegere PP, Sianos G, McFadden EP, de Feyter PJ, van Domburg RT, Serruys PW: Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries). Am J Cardiol 96:358-362, 2005
12. Kuchulakanti PK, Chu WW, Torguson R, Clavijo L, Wolfram R, Mishra S, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R: Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus. Am J Cardiol 98:187-192, 2006
13. Saia F, Piovaccari G, Manari A, Santarelli A, Benassi A, Aurier E, Sangiorgio P, Tarantino F, Geraci G, Vecchi G, Guastaroba P, Grilli R, Marzocchi A: Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry. J Am Coll Cardiol 48:1312-1318, 2006
14. Seabra-Gomes R: Percutaneous coronary interventions with drug eluting stents for diabetic patients. Heart 92:410-419, 2006
15. Reiber JH, van der Zwet PM, Koning G, von Land CD, van Meurs B, Gerbrands JJ, Buis B, van Voorthuisen AE: Accuracy and precision of quantitative digital coronary arteriography: observer-, short- and medium-term variabilities. Cath Cardiovasc Diagn 28:187-198, 1993
16. Tsuchida K, Garcia-Garcia HM, Ong AT, Valgimigli M, Aoki J, Rademaker TA, Morel MA, van Es GA, Bruining N, Serruys PW: Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial. Catheter Cardiovasc Interv 67:188-197, 2006
17. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM: Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 82:1193-1202, 1990
18. Mauri L, Orav EJ, O'Malley AJ, Moses JW, Leon MB, Holmes DR Jr, Teirstein PS, Schofer J, Breithardt G, Cutlip DE, Kereiakes DJ, Shi C, Firth BG, Donohoe DJ, Kuntz RE: Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 111:321-327, 2005
19. Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O'shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW: Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol 45:1193-1200, 2005